CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to REC.MI

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

3

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Benign Prostatic Hyperplasia

View Full Landscape
Drug Information

Target Indication

Benign Prostatic Hyperplasia

Clinical Trial

NCT00359905

Last updated: 6/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA1/7/2019

Silodosin Recordati

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men.

View on EMA
EMA1/29/2010

Urorec

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

View on EMA
EMA1/29/2010

Silodyx

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.